These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12614556)

  • 21. Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro.
    Zhang N; Erjala K; Kulmala J; Qiu X; Sundvall M; Elenius K; Grénman R
    Radiother Oncol; 2009 Sep; 92(3):388-92. PubMed ID: 19447510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-diamminedichloroplatinum cisplatin on human ovarian cancer.
    Tang Q; Chen D
    Biomed Mater Eng; 2014; 24(1):711-22. PubMed ID: 24211956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice.
    Landrito JE; Yoshiga K; Sakurai K; Takada K
    Anticancer Res; 1994; 14(1A):113-8. PubMed ID: 8166436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo.
    Liu CD; Kwan D; Saxton RE; McFadden DW
    J Surg Res; 2000 Sep; 93(1):137-43. PubMed ID: 10945955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [IL-2 gene and cisplatin combined therapy for head and neck squamous cell carcinoma].
    Liu S; Lin Y; Tang S; Yang H; Liang C
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Jun; 19(3):191-3. PubMed ID: 12539412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin].
    Fujiwara T; Ogawa N; Kagawa S; Nishizaki M; Yasuda T; Tanaka N; Orita K; Roth JA
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):1085-8. PubMed ID: 8687228
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin.
    Uehara M; Inokuchi T; Ikeda H
    J Oral Maxillofac Surg; 2006 Mar; 64(3):390-6. PubMed ID: 16487799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck.
    Wani MK; Koseki Y; Yarber RH; Sweatman TW; Ahmed A; Samant S; Hengesteg A; Israel M; Robbins KT
    Laryngoscope; 2000 Dec; 110(12):2026-32. PubMed ID: 11129014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
    Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM
    Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
    Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
    Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours.
    Harrington KJ; Rowlinson-Busza G; Uster PS; Stewart JS
    Cancer Chemother Pharmacol; 2000; 46(1):10-8. PubMed ID: 10912572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma.
    Levitt JM; Jian W; Lerner SP; Sonpavde G
    Urol Oncol; 2013 Feb; 31(2):234-40. PubMed ID: 21723160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phototherapy with argon lasers and Rhodamine-123 for tumor eradication.
    Castro DJ; Saxton RE; Fetterman HR; Castro DJ; Ward PH
    Otolaryngol Head Neck Surg; 1988 Jun; 98(6):581-8. PubMed ID: 3138616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laser chemotherapy of human carcinoma cells with three new anticancer drugs.
    Eshraghi AA; Castro DJ; Paiva MB; Graeber IP; Jongewaard N; Arshadnia S; Lamas G; Soudant J; Saxton RE
    J Clin Laser Med Surg; 1997 Feb; 15(1):15-21. PubMed ID: 9467337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
    Nishita T
    Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
    Shibamori M; Sato M; Uematsu N; Nakashima T; Sato A; Yamamura Y; Sasabe H; Umehara K; Sakurai K
    J Pharmacol Sci; 2015 Sep; 129(1):18-25. PubMed ID: 26320673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
    Uygun K; Bilici A; Karagol H; Caloglu M; Cicin I; Aksu G; Fayda M; Uzunoglu S
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):601-5. PubMed ID: 19123002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.